Cold and flu medication shortage across Canada is a 'wake up call,' pharmacists sayPeople across the country are struggling to find adult cold, cough and flu medications, right on the heels of a children's fever and pain medication shortage that still hasn't been fully resolved. Paxlovid prescriptions in Ontario double after pharmacists allowed to prescribeBetween Dec. 12 and 29, the amount of Paxlovid courses dispensed rose by 129%. Nuvaxovid COVID-19 vaccine approved for adolescents and for first booster dose in adults Protein subunit COVID-19 vaccine may be an option for individuals who are unable or not willing to receive an mRNA COVID-19 vaccine. Drug News—November/December 2022 A review of new launches, new indications, new dosage forms and Health Canada advisories. Sumatriptan identified as highest-risk drug leading to acute angle-closure glaucoma Large Korean study pinpoints 61 drugs associated with acute angle-closure glaucoma. Two new biosimilar insulins now available in Canada Viatris is introducing Kirsty (insulin aspart) and Semglee (insulin glargine). Tezspire now available for add-on maintenance treatment of severe asthma First biologic for severe asthma targeting thymic stromal lymphopoietin is effective regardless of phenotype. Breztri Aerosphere now available for long-term maintenance treatment of COPD Second 'triple-therapy' combination product approved in Canada for COPD maintenance treatment to reduce exacerbations and treat airflow obstruction. Will angiotensin receptor II blockers play a role in epilepsy prevention? Study examines whether ARB therapy is associated with a decreased incidence of new onset epilepsy in patients with hypertension. Health Canada approves two therapies for COVID-19 treatment Single-dose Evusheld is now indicated for treating mild/moderate COVID-19 and Actemra IV is now approved for treating COVID-19 in hospitalized adults. First Previous 65 66 67 Next Last
